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Many functions of the mammalian target of rapamy-
cin (mTOR) complex 1 (mTORC1) have been defined,
but relatively little is known about the biology of an
alternative mTOR complex, mTORC2. We showed
that conditional deletion of rictor, an essential subunit
of mTORC2, impaired differentiation into T helper 1
(Th1) and Th2 cells without diversion into FoxP3+
status or substantial effect on Th17 cell differentia-
tion. mTORC2 promoted phosphorylation of protein
kinase B (PKB, or Akt) and PKC, Akt activity, and
nuclear NF-kB transcription factors in response to
T cell activation. Complementation with active Akt
restored only T-bet transcription factor expression
and Th1 cell differentiation, whereas activated PKC-
q reverted only GATA3 transcription factor and the
Th2 cell defect of mTORC2mutant cells. Collectively,
the data uncover vital mTOR-PKC and mTOR-Akt
connections in T cell differentiation and reveal
distinct pathwaysbywhichmTORC2 regulatesdevel-
opment of Th1 and Th2 cell subsets.
INTRODUCTION
So that specific needs for T cell help in immunity can be met,
naive CD4+ T cells can differentiate into functionally distinct
subsets of effector and regulatory (Treg) T cells after activation
(Glimcher and Murphy, 2000; Zhu and Paul, 2008). This flexibility
allows modulation of antigen-specific responses and adaptive
immunity against microbes. Among these subsets, T helper 1
(Th1) cells produce cytokines such as IFN- g after activation
and IL-12 and IFN-g after exposure to signals elicited by intracel-
lular microbes (Glimcher and Murphy, 2000). A Th2 cell subset is
induced by different cues and produces a distinct program of
cytokines (IL-4, -5, and -13) for allergic and antiparasitic
responses. Several more effector states can develop from naive
CD4+ T cells: IL-17-producing Th17, induced Treg, IL-9-producing Th9, and IL-21-producing follicular helper (Tfh) cells
(Locksley, 2009). Although the balance among these CD4
subsets is crucial, much remains unknown as to how signals
are integrated to determine T cell fate and function.
T cell activation by antigen is essential for the development of
effectors from naive T cells, and this process is strongly potenti-
ated by engagement of costimulatory receptors on the T cells.
CD28 dramatically enhances Th1 or Th2 cell responses (Kane
et al., 2001; Kuchroo et al., 1995). Similarly, inducible costimula-
tors such as ICOS and OX40 strongly enhance Th2 cell develop-
ment and Th1 cell responses (Lane, 2000). Thus, costimulation of
T cell receptor (TCR) signaling is vital for efficient development of
several CD4+ T cell effector states. Furthermore, the precise
quantitative and qualitative signaling elicited by the TCR or cos-
timulators can guide the balance of differentiation into the
different T helper subsets (Constant and Bottomly, 1997).
As such, signaling molecules activated by TCR and costimula-
tion are likely to be of vital importance in identifying means of
manipulating the properties of immune responses.
Key molecules activated by costimulation include the
mammalian Target of Rapamycin (mTOR), protein kinase B
(PKB, also known as Akt), and protein kinase C (PKC)-q (Huang
et al., 2002; Lin et al., 2000). Upon TCR engagement and CD28
ligation, PKC-q is phosphorylated and enhances T helper
responses, in part by promoting nuclear translocation of NF-kB
transcription factors (Coudronniere et al., 2000; Wang et al.,
2004). In parallel, TCR engagement with costimulation also
increases phosphatidylinositol 3-kinase (PI3K) activity. PI3K
increases amounts of phosphatidyl inositol (3,4,5)-triphosphate
(PIP3), which recruits the PI3K-dependent kinase (PDK) 1 and
activates Akt via phosphorylation of a conserved residue termed
Akt (T308) (Scheid et al., 2002). Among its molecular targets, Akt
leads to activation of mTOR (Kane and Weiss, 2003).
The importance of understanding of how specific signaling
pathways impact T cell physiology is underscored by the
successes and toxicities of immune suppressant drugs such
as rapamycin, which targets mTOR. Rapamycin can inhibit
proliferation of conventional T lymphocytes without blocking
Treg cells (Battaglia et al., 2005; Valmori et al., 2006) and
appears to bias the acquisition of CD4+ T cell functions inasmuch
as it represses Th1, Th2, and Th17 cell development whileImmunity 32, 743–753, June 25, 2010 ª2010 Elsevier Inc. 743
Figure 1. Costimulation Enhances Phosphoryla-
tion of Akt HM (S473)
Phosphorylated and total pools of the indicated proteins
were analyzed by immunoblotting. CD4+ T cells were
stimulated (40 min) with 0.5 mg/ml plate-bound aCD3,
2.5 mg/ml of soluble aCD28, or both, as described in the
Experimental Procedures. Bar graphs quantify phosphor-
ylation of Akt, S6K1, and PKC(-q), with each sample
normalized to the level of unphosphorylated protein in
one experiment representative of three replicates.
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2007). There are at least two independent pools of mTOR in
mammalian cells, of which the first is an acutely rapamycin-
sensitive assembly termed mTOR complex 1 (mTORC1)
(Laplante and Sabatini, 2009). A major role for mTORC1 in T
lineage cells is clear from the effects of rapamycin and loss-of-
function models for Akt and PDK1 (Hinton et al., 2004; Juntilla
et al., 2007). Thus, although mTORC1 can also be activated by
Akt- and PI3K-independent mechanisms (Carrie`re et al., 2008;
Fang et al., 2001), an important linear pathway to mTORC1 via
Akt is solidly established and the data establish Akt and
mTORC1 as key transducers of proliferative and differentiative
signals in the T cell lineage.
After its activation by PDK1, Akt can be further phosphorylated
at a C-terminal hydrophobic motif (HM) termed S473 (Scheid
et al., 2002). This modification executed by PDK2 activities
increased the cell-free in vitro activity of T308-phosphorylated
Akt (Chan and Tsichlis, 2001; Scheid et al., 2002). PKC-b, DNA-
PK, and integrin-linked kinase can provide PDK2 function in
particular cell types (DongandLiu, 2005).More recently, a second
multiprotein complex that includes mTOR, mTORC2, has been
identified as a major PDK2 (Sarbassov et al., 2005). In contrast
to mTORC1, relatively little is known about the biological roles
and functions of mTORC2 (Laplante and Sabatini, 2009).
mTORC2 requires unique components—rictor and SIN1—that
arenot sharedbymTORC1 (Jacintoet al., 2006). LossofmTORC2
is embryonic lethal, but specific cellular or physiological targets in
development are unknown (Guertin et al., 2006; Shiota et al.,
2006). Intriguingly, mTORC2 was vital for Akt phosphorylation at
T308 as well as S473 in multiple cell lines (Sarbassov et al.,
2005) but not in rictor- or SIN1 null mouse embryonic fibroblasts
(MEFs) (Guertin et al., 2006; Jacinto et al., 2006). Overall, it
remains unclear whether mTORC2 impacts Akt activity or its
targets in T cells. Apart from Akt, mTORC2 can phosphorylate744 Immunity 32, 743–753, June 25, 2010 ª2010 Elsevier Inc.PKC isoforms or regulate their effects on actin
in tumor cells, but the impact of this capacity
on physiological functions is not clear (Facchi-
netti et al., 2008; Ikenoue et al., 2008). Finally,
prolonged exposure of tumor cell lines or mice
to rapamycin can either reduce or increase
activity of mTORC2 (Sarbassov et al., 2006).
Thus, the degree to which mTORC2 might
contribute to rapamycin effects is unclear.
Because there is no direct evidence of an
mTORC2 function in immunity, we analyzed
a conditional loss-of-functionmodel by using tar-
geted alleles encoding the essential mTORC2subunit rictor. The principal role revealed for rictor after CD4+
T cell activation was promotion of differentiation into Th1 and
Th2 cell subsets. In contrast, mTORC2 inhibited the induction of
regulatory T cells under permissive conditions, but the defective
cells exhibited no diversion from T helper cell differentiation into
FoxP3+ status or marked abnormality of Th17 cell generation.
Biochemical analyses revealed thatmTORC2deficiency impacted
both Akt activity and phosphorylation of conserved PKC motifs.
Strikingly, constitutively active Akt rescued T-bet expression and
Th1 but not Th2 cell differentiation, whereas PKC-q led to a recip-
rocal outcome. Thus, each of these mTORC2 targets selectively
suppressed distinct defects of rictor-deficient cells, revealing an
important branchpoint downstream from this signal-transducing
complex in T cells.
RESULTS
Costimulation and T Cell Activation Induce
Rictor-Dependent Akt HM Phosphorylation
We first analyzed the relationship of TCR costimulation to Akt
phosphorylation and mTORC2 activity by using combinations
of anti-(a)CD3 and aCD28. Anti-CD28, alone and synergistically
with aCD3, increased phosphorylation not only at Akt T308 but
also at the Akt S473 (Figure 1), indicating that costimulation
induced PDK2 activity. Costimulation also increased the phos-
phorylation of p70 ribosomal S6 protein kinase (S6K1) at T389,
a site modified by mTORC1. mTORC2 also mediates serum-
induced PKC phosphorylation at turn (TM) and hydrophobic
(HM) motifs (Guertin et al., 2006; Ikenoue et al., 2008), and we
found CD28 stimulation enhanced PKC-q-mediated PKC HM
and TM phosphorylation (Figure 1).
To identify roles of mTORC2 in mature T cells, we used condi-
tional inactivation of rictor. Deletion driven by Cre early in the
T cell lineage (i.e., starting at the DN2 stage) decreased
Figure 2. Impaired Akt Phosphorylation and
Activity in Rictor-Deficient T Cells
(A) T cell numbers from lymphoid organs of 6- to 8-week-
old mice. Shown are mean (±SEM) numbers of cells of the
indicated types (spleen and pooled lymph nodes of eight
WT and eight cKO mice; *p < 0.05)
(B) Previously activated CD4+ T cells were stimulated
(40 min) with aCD3, aCD28, or both and analyzed by
immunoblotting (as in Figure 1A). Akt S473 and S6K1
T389 phosphorylation were normalized to amounts of un-
phosphorylated protein in the same sample and then to
amounts in WT CD4+ cells (bar graphs from one experi-
ment representative of two complete replicates, with addi-
tional replicates of aCD3 + aCD28 versus control).
(C and D) Decreased Akt enzymatic activity in T cells defi-
cient for mTORC2. (C) shows an Akt activation loop (T308)
phosphorylation in T cells lacking rictor (one result repre-
sentative of two replicates with similar results). (D) shows
a representative result assaying Akt kinase in extracts of
WT and cKO CD4+ T cells. Cells were activated and
restimulated as in (B); numbers represent quantified
signals, normalized to the amounts of Akt in each sample
and expressed as arbitrary light units with resting WT cells
set as 1. Samples are as shown in (C). Additional informa-
tion is provided in Figure S1.
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abnormalities of the resultant T cell repertoire (data not shown).
Using a codon-optimized Cre cDNA that is directed to start
expression after thymocyte progression to the double positive
(DP) stage by the distal Lck promoter (‘‘dLck-iCre’’) (Zhang
et al., 2005),wedetecteddeletion in T cells,whereas floxedalleles
were almost all intact in the thymus and in Thy1- cells fromperiph-
eral lymphoid organs (Figure S1A available online). Thymocytes
from dLck-iCre+ Rictorfl/fl (abbreviated as cKO) mice and wild-
type controls showed no abnormalities except for very modest
decreases in CD8 SP cells and TCRhi HSAlo thymocytes (Figures
S1B–S1D). Spleen and lymph node CD4+ T cell numbers were
normal, whereas CD8+ T cells decreased slightly (Figure 2A) and
frequencies of CD44hi, CD62Lhi, and CD25hi cells were similar in
cKO and WT mice (Figures S1F–S1I). Thus, mature CD4+ T cells
developed normally when rictor deletion was deferred during
thymic differentiation, whereas a modest quantitative defect
impacted production of CD8+ T cells.
PDK2 function downstream from the TCR and CD28 in mature
CD4+ T cells was analyzed by comparison of Akt S473 phos-Immunity 32,phorylation in WT and cKO cells. This modifica-
tion was decreased in rictor-deficient T cells
after TCR stimulation, costimulation, or both
(Figure 2B). Loss of mTORC2 has been reported
either to eliminate the phosphorylation of Akt
T308 in some cells (Sarbassov et al., 2005) or
to have no impact on this activatingmodification
(Guertin et al., 2006; Jacinto et al., 2006; Shiota
et al., 2006). Decreased P-Akt T308, albeit not
a complete loss, was observed in cKO T cells
(Figure 2C). Despite the residual T308 phos-
phorylation, TCR and CD28 engagement
stimulated Akt enzymatic activity in mTORC2-deficient T cells far less than WT controls (Figure 2D). Thus,
T cell activation-induced Akt activity relies on mTORC2. In
contrast, phosphorylation of S6K1—which is impacted by Akt
but can also be affected through other pathways—was not
decreased in cKO cells.
Rictor Promotes a Restricted Set of T Helper Cell Fate
Choices
Because rictor was vital for full Akt activity in T cells, we explored
its impact on activation, differentiation, and function of T cells.
We observed a dramatic decrease in Th2 cell differentiation
among naive CD4+ T cells from cKO mice (Figures 3A and 3B).
Comparisons of cKO to WT littermates also revealed impaired
Th1 cell differentiation (Figures 3A and 3B). In contrast, no
marked defect in Th17 cell development was observed (Figures
3A and 3B), indicating that rictor-containing complexes selec-
tively promoted Th1 and Th2 cell differentiation.
Constitutively active Akt can inhibit Treg cell development
(Haxhinasto et al., 2008), whereas rapamycin enhances their
development at the expense of Th17 cell differentiation (Blazar743–753, June 25, 2010 ª2010 Elsevier Inc. 745
Figure 3. mTORC2 Selectively Regulates
Differentiation of T Helper Cell Subsets
and Responses
(A and B) CD4+ T cells were cultured for 5 days
under Th1, Th2, or Th17 cell conditions, restimu-
lated with aCD3 + aCD28, and analyzed by (A)
flow cytometry for intracellular cytokines or (B)
ELISA with culture supernatants. Shown are pro-
files for IFN-g and IL-4 in the CD4+ viable cell
gate or IL-17A and IFN-g in rictor-deficient CD4+
T cells (one result representative of three replicate
experiments [A]) and means (±SEM; n = 5 [B]).
(C) mTORC2 impedes induction of iTreg cell
phenotype. Naive CD4+ T cells (leftmost panels)
from WT and cKO mice were activated (aCD3 +
aCD28) and grown in the absence or presence of
TGF-b for 3 days. Shown are histograms of
FoxP3 expression in the CD4+ gate of freshly iso-
lated naive T cells or activated T cells, from one
representative experiment.
(D) Normal Treg cell populations under T helper-
inducing conditions. CD4+ T cells activated and
cultured under the Th1, Th2, and Th17 cell condi-
tions were analyzed by flow cytometry as in (C).
(E–I) Impairment of responses in vivo. Each
symbol represents one mouse, and solid lines
denote mean values; *p < 0.05 (two independent
experiments).
(E and F) Impaired IgG2a, but not IgG3, anti-KLH
response in rictor cKO mice. Groups of WT and
cKO mice were immunized with KLH in IFA and
boosted with KLH in IFA 14 days later. Sera were
collected on day 19, 5 days after the boost. Shown
arecaptureELISA results for IgG2a (E) and IgG3 (F).
(G) WT and cKO mice were challenged with L.
monocytogenes and analyzed as described in
the Experimental Procedures. Shown are log10-
scale results of ELISPOT assays (two independent
experiments) performed with the immunodomi-
nant class II MHC peptide LLO190-201 as indicated
(10, 100 nM); each dot represents one mouse, and
solid lines denote mean values (panels are ar-
ranged vertically).
(H and I) Decreased IgG1 and IgE production in
rictor cKO mice. As in (E) and (F), but mice were immunized with low-endotoxin ovalbumin in alum, and ELISA results shown are for Ag-specific IgE (H) and
IgG1 (I); ANOVA across the full dilution curves and all indicated differences were significant at p < 0.05. Additional information is provided in Figure S2.
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state frequency of Treg cells (Figure S2A). However, FoxP3+
progeny developed from activated cKO CD4+ T cells supple-
mented only with TGF-b at a greater efficiency than controls
(Figure 3C and Figure S2B). In contrast, normal frequencies of
theFoxP3+populationwereobserveddespite themTORC2defect
when activated CD4+ T cells received strong T helper-differenti-
ating signals (Figure3D). These results show thatmTORC2 inhibits
iTreg cell differentiation under conditions already favorable to this
process but rictor deficiency neither prevented Th17 cell develop-
ment nor diverted developing effectors into a FoxP3+ population if
IL-4 or Th1 cell-promoting cytokines were present.
To test whether rictor influences an immune response in vivo,
we immunizedWT and cKOmicewith keyhole limpet haemocya-
nin (KLH). The Ag-specific IgG2a response of cKO mice was
significantly reduced, whereas IgG2b and IgG3were not (Figures
3E and 3F and Figure S2C). T helper cell-derived IFN-g is crucial
for isotype switching to IgG2a, suggesting mTORC2 might be746 Immunity 32, 743–753, June 25, 2010 ª2010 Elsevier Inc.important for type 1 helper function. Consistent with this, the
frequency of IFN-g-producing CD4+ T cells was lower in
lymphoid samples from cKO mice in an infectious challenge
model (Figure 3G and Figures S2D and S2E). Moreover, total Ig
and IgG1 (Figure S2f, g) anti-KLH responses also were weaker.
Tomeasure IgE concentrations, mice were immunized with oval-
bumin in alum. A reduced overall Ag-specific IgG response was
observed again and amounts of serum IgE anti-ovalbumin were
reduced in the cKO mice (Figures 3H and 3I; Figure S2H). These
results suggested a requirement for mTORC2 in both type 1 and
type 2 T cell help to Ab class switching, and the aggregate find-
ings indicate that rictor functions in vivo to mediate a subset of
differentiation events and regulates the properties of T-B help.
Rictor Promotes Proliferation without Impacting
Survival
The best-known functions of Akt are its suppression of
apoptosis and acceleration of cell cycling (Manning and Cantley,
Figure 4. Decreased Proliferation but Normal Survival of Rictor-
Deficient T Cells
(A) Splenocytes of WT and rictor cKO mice assayed for 3H-thymidine incorpo-
ration 48 hr after activation with aCD3 + aCD28 (representing three replicate
experiments).
(B) As in (A), except that cells were analyzed by flow cytometry for BrdU incor-
poration (left panel) or division history with CFSE partitioning (right panel).
Shown are histograms of events in the CD4+ and viable lymphoid gates from
one experiment representative of three replicates.
(C) Mean (±SEM) from one of two replicate experiments measuring viable
CD4+ T cell numbers after triplicate cultures (1–3 days) with or without IL-4, ex-
pressed as a percentage of the input viable cell counts.
(D) Spleen cells were cultured (20 hr) in the presence or absence of IL-4 and
assayed by TUNEL. Shown are flow cytometry profiles for CD4+ cells; numbers
denote the percentage of TUNEL-positive cells in one experiment representa-
tive of four replicates.
(E) Cells were irradiated, cultured in the presence or absence of IL-4, and as-
sayed by TUNEL. Additional information is provided in Figure S3.
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cient T cells, at least partly because of a decreased rate of
G1-S transitions (Figures 4A and 4B). Rictor-deficient CD8+
T cells as well as CD4+ T cells were defective; moreover, IL-4-
dependent proliferation of both CD4+ and CD8+ T cells was
also attenuated (Figures S3A–S3D). Cytokine receptors that
share a common gamma chain signal protection against death
by neglect, radiation-induced DNA damage, or etoposide-
induced DNA damage. However, there was no decrease in
survival rates of rictor-deficient T cells or increase in their
apoptosis in the absence or presence of cytokines (Figures
4C–4E; Figure S3E and S3F). Similarly, we observed no sensiti-
zation to apoptosis after restimulation of activated CD4+ T cells
(Figure S3G). Thus, mTORC2 mediates T cell proliferative
signaling predominantly via cell cycle regulation rather than
suppression of apoptosis.
Akt and PKC Mediate mTORC2 Regulation of T Helper
Cell Differentiation
We transduced constitutively activated kinases targeted by
mTORC2 into rictor-deficient T cells to determine the functional
impact of Akt and PKC on the defects of T helper cell differenti-
ation. Th1 cell differentiation of cKOCD4+ T cells was rescued by
the constitutively active mutant Myr-Akt (Figures 5A and 5B;
Figures S4A and S4B). An Akt mutant activated by phospho-
mimetic residues at T308 and S473 [Akt(DD)] also suppressed
the differentiation defect. In contrast, Akt(DA), which is refractory
to S473 phosphorylation, did not raise the frequency of cKO Th1
cells (Figures S4A and S4B). Akt(DD) also restored normal prolif-
eration to cKO T cells (Figure S4D). Strikingly, however, Akt did
not rescue the Th2 cell differentiation defect imposed by loss
of mTORC2 function (Figures 5C and 5D). Thus, mTORC2 modi-
fication of Akt promotes Th1 cell differentiation but is not suffi-
cient to explain the defect of Th2 cell differentiation.
Although mTORC2 phosphorylates PKCs at sites not thought
of as major regulators of catalytic activity, we hypothesized that
a PKC pathway might provide a functional link between
mTORC2 and Th2 cell differentiation. Indeed, transduction of
a constitutively active PKC-q mutant (Liu et al., 2001) reverted
the Th2 cell defect of cKO CD4+ T cells, yet did not impact the
frequency of IFN-g-positive cells (Figure 5A; Figures S4A and
S4C). Akt and PKC-q might collaborate as relays downstream
from mTORC2, but cotransduction of these kinases into cKO
CD4+ T cells showed only a small additive effect for Th2 cell
differentiation (Figure S4E). As a mechanism for decreases in
Th1 and Th2 cell differentiation when mTORC2 is compromised,
amounts of the lineage-determining transcription factors T-bet
and GATA-3 were substantially reduced in cKO CD4 T cells
(Figures 5E and 5F). Moreover, Akt restored WT amounts of T-
bet expression to cKO T cells developing in Th1 cell conditions
and failed to reverse the deficit of GATA3 in Th2 cell differentia-
tion (Figures 5G and 5H). Conversely, constitutively active PKC-q
restored GATA3 but not T-bet under Th2 and Th1 cell conditions,
respectively (Figures 5G and 5H).
Because mTORC2 differentially influenced fate choices of
mature T cells, we explored relative activities of PDK1, PDK2,
and mTORC2 in developing effectors. In comparing nonpolariz-
ing, Th1, Th2, and Th17 cell conditions, there weremodest differ-
ences in amounts of PKC-q and its HM-phosphorylated form andin ratios of Akt P-S473 to P-T308 (Figure S4F). STAT transcrip-
tion factors guide choices for CD4+ T cells during T helper devel-
opment and control the ‘‘master regulators’’ of Th1, Th2, and
Th17 cell fates. However, tyrosine phosphorylation of the rele-
vant STAT transcription factors was normal in cKO cells
(Figure 6A; Figure S5A). P-STAT induction in cells subjected to
inhibition of mTORC1 and mTORC2, or PI3K, was also normal
(Figures S5B–S5E). It was intriguing that rapamycin strongly
inhibited T cell proliferation despite activated Akt or PKC-q
expression, but also impacted Th1 and Th2 cell frequencies
among the hypo-proliferative cells (Figures S5F–S5I). This
suggests mTORC1 may also relay signals promoting theseImmunity 32, 743–753, June 25, 2010 ª2010 Elsevier Inc. 747
Figure 5. Reciprocal Effects of Akt and
PKC-q, Downstream from mTORC2, in T
Helper Cell Differentiation
(A–D) CD4+ T cells were activated under nondiffer-
entiating conditions, transduced with the indi-
cated constructs, cultured for 5 days under
(A and B) Th1 cell or (C and D) Th2 cell polarizing
conditions, restimulated, and analyzed by flow cy-
tometry. Shown are flow data for IFN-g and IL-4 in
the GFP+ CD4+ gate (A and C) (representative
result from one ofR 3 replicate experiments).
(B and D) Experimental results are summarized as
mean (±SEM) percentage of IFN-g+ or percentage
of IL-4+ cells in the in the GFP+ CD4+ gate.
(E and F) Impaired T-bet and GATA3 expression in
rictor-deficient T cells. CD4+ T cells were cultured
(4 days) in Th1 or Th2 cell conditions and assayed
with RT-PCR on serial 5-fold template dilutions to
compare levelsofmRNAs (E)or immunoblotting (F).
(G and H) Selective reversion of decreased T-bet
or GATA-3 expression in rictor cKO CD4+
T cells. CD4+ T cells were activated, transduced,
switched to differentiating conditions, and
analyzed by FACS as in (A)–(D), except that intra-
cellular stains were for T-bet (G) and GATA-3 (H) in
the GFP+ CD4+ gate. Shown are representative
histograms for the signal of isotype controls (thin
line) or a(T-bet or GATA-3, thick line) in one exper-
iment representative of two replicates. Inset
numbers represent the net signal as MFI (active
Ab-isotype signal) in each sample. Additional
information is provided in Figure S4 and the
Experimental Procedures.
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cell differentiation via Akt, whereas PKC-q serves as the relay
for the Th2 cell fate, with each of these kinases exerting key
effects independent from the STAT pathway.
Targets Downstream from mTORC2 in T Cells
The findings raised questions about how rictor affects biochem-
ical targets of mTORC2, Akt, and PKC-q to regulate the key tran-
scriptional determinants of Th1 or Th2 cell fates. The Akt target
FoxO1 represses cell cycling, enhances apoptosis, and has
been identified as a regulator of T-bet and galectin-3, proteins
that promote Th1 cell responses (Jiang et al., 2009; Ouyang
et al., 2009). Consistent with the reductions in Akt activity and
T-bet expression (Figures 2C, 2D, 5E, and 5F), P-FoxO1 was
decreased in cKO T cells though an analogous phosphorylation
of GSK-3b was unaffected (Figures 6B and 6C). There also was
no significant decrease in phospho-S6K1 (Figure 6C), a target of
mTORC1 regulated indirectly by Akt. GSK-3b(p-S9) and748 Immunity 32, 743–753, June 25, 2010 ª2010 Elsevier Inc.mTORC1 are targeted by other kinases
in addition to Akt so the results with
GSK-3 and S6K1 may be due to func-
tional redundancy. However, the findings
show that mTORC2 relays input signals
that are nonredundant for FoxO1 as
an Akt target. Because TCR-induced
P-FoxO1 as well as T-bet were
decreased in cKO T cells, we also mea-sured expression of galectin-3 and found it was reduced in
cKO T cells (Figure 6D).
Unlike the complete deletion in T cells (Kerdiles et al., 2009;
Ouyang et al., 2009), decreased P-FoxO1 would only diminish
repression by FoxO1, so some FoxO1 target genes might not
be impacted by mTORC2 dysfunction. Indeed, mRNA expres-
sion was normal for the FoxO1 target Il7R (Figure S6A). Recent
work on CD8+ T cells reported that PI3K regulates CD62L tran-
scription by a rapamycin-sensitive pathway involving regulation
of Klf2 (Sinclair et al., 2008). Although there was no difference in
CD62L expression at the surface of freshly isolated CD4+ T cells,
we observed marked reductions in the frequency CD62Llo CD4+
(Figure 7A) and CD8+ (Figure S6B) cells after activation of cKO
T cells. However, neither Klf2 nor Sell (encoding CD62L) mRNA
expression was significantly altered in CD4+ cKO cells (Fig-
ure S6A). Thus, mTORC2 impacts CD62L downregulation after
T cell activation by a nontranscriptional mechanism. Apart from
this identification of a role distinct from the rapamycin-inhibited
Figure 6. mTORC2 Exerts Differential Effects on Downstream
Targets while Sparing Stat Protein Tyrosyl Phosphorylation
(A) Normal induction of phosphotyrosyl STAT transcription factors in rictor cKO
mice T cells. CD4+ T cells were treated 40minwith the indicated cytokine or left
unstimulated, then analyzed by immunoblotting with anti-P-STAT6Y641 or
P-STAT3Y705.
(B) Naive, freshly purified CD4+ T cells fromWT and cKOmice were stimulated
as in Figure 1 and analyzed by immunoblotting (one experiment representative
of two replicates).
(C) Because of limiting amounts of protein from naive T cells, purified cells were
activated, rested after growth in vitro, restimulated, and analyzed (as for B).
The bar graph presents the result of quantitation of the signal for P-FoxO1
(one experiment representative of three replicates).
(D) Impairment of the activation-induced increase in expression of galectin-3,
a FoxO1-regulated gene. FACS profiles for galectin on freshly isolated and
activated (aCD3, aCD28, and 10 ng/ml IL-4 for 2 days) CD4+ T cells in one
experiment representative of two replicates, and a bar graph quantitating
the results are shown. Additional information is provided in Figure S5.
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controlling mRNA expression for known FoxO1-regulated genes
involved in Th1 cell differentiation.
mTORC2 phosphorylates PKC-a and regulates 3T3 and HeLa
cell cytoskeletons (Jacinto et al., 2004; Sarbassov et al., 2004),
but no role in T cells is known. Phosphorylation of PKC HM
and PKC-q TM—direct targets of mTORC2 —also decreased
in cKO T cells (Figures 6B and 6C). PKC-q is essential for
coupling TCR and CD28 costimulation to nuclear amounts of
NF-kB and Th2 cell differentiation (Cannons et al., 2004; Mars-
land et al., 2004). Importantly, TCR-stimulated NF-kB amounts
in nuclei of rictor-deficient CD4+ T cells were substantially
decreased (Figure 7B). Moreover, TCR induction of a Carma1-
dependent NF-kB-driven promoter was decreased in CD4+
cKO cells (Figure 7C), whereas transfection of cKO CD4+
T cells with the PKC-q construct restored promoter activity to
the amount of WT cells transfected with empty vector
(Figure 7D). These data indicate that PKC-dependent NF-kB
activity downstream from the TCR depends on mTORC2. Of
note, in addition to decreased NF-kB transcription factors in
the nuclei of cKO CD4+ T cells, Bcl-3 was also diminished
(Figure 7E). This atypical IkB-like protein converts NF-kB1-p50
homodimers to transcriptionally active complexes, so that
GATA3 and Th2 cell differentiation are decreased in Bcl-3-defi-
cient T cells as well as NF-kB1-p50 null cells (Corn et al.,
2005). Consistent with this, decreased GATA-3 expression in
mTORC2-deficient developing Th2 cells were restored by acti-
vated PKC-q (Figures 5F and 5H). PKC-q also promotes
increased binding of the integrin LFA-1 to ICAM-1 (Letschka
et al., 2008). Consistent with a functional impact of mTORC2
on the PKC pathway in T cells, the activation-induced increase
in LFA-1 binding to ICAM-1 was impaired in cKO T cells
(Figure 7F). Taken together with the data on Akt-targeted
FoxO1 and reversion results, the findings place Akt and PKC
functions downstream from mTORC2 in T cells. Further, the
data provide evidence of a functional dichotomy in T helper
cell differentiation, such that Akt mediates mTORC2 regulation
of Th1 cell development and PKC links mTORC2 to differentia-
tion into Th2 cells.
DISCUSSION
We have shown that mTORC2 selectively promotes subsets of T
helper cell differentiation and restrains acquisition of FoxP3
expression, but a defect of mTORC2 does not divert differenti-
ating populations into a Treg cell-like fate. Thus, Ag-specific anti-
body isotypes driven by type 1 and type 2 help decreased in cKO
mice, and proliferation-independent analyses revealed blocks to
Th1 and Th2 but not Th17 cell differentiation. Dissection of
mTORC2 effects on differentiation, survival, and cell cycling
provided evidence of an unexpected hierarchy in the roles of
this complex. T cell survival was unaffected and proliferation
decreased only modestly despite decreased Akt activity, yet the
effects on differentiation were substantial but selective. TCR-
CD28-induced increases in phosphorylation of both Akt S473,
a direct target of mTORC2, and the T308 residue, which is the
most critical determinant of Akt activation by PDK1, were attenu-
ated in cKOT cells. In addition, the defect of mTORC2 also weak-
ened functional signaling to PKC. This biochemical bifurcationImmunity 32, 743–753, June 25, 2010 ª2010 Elsevier Inc. 749
Figure 7. mTORC2Regulation of NF-kBActivity via
PKC
(A) Regulation of CD62L expression on T cells. Shown are
FACS profiles of CD62L and CD44 expression on freshly
isolated or activated (as in Figure 4) CD4+ T cells (one
experiment representative of four replicates). Inset
numbers represent frequencies (%) in each quadrant.
(B) Rictor dependence of nuclear NF-kB subunits and the
NF-kB-regulated protein Bcl-3 after TCR-CD28 costimu-
lation. CD4+ T cells were activated and a portion of each
was restimulated with aCD3 and aCD28 as in Figure 6.
After separation of nuclear (N) and cytosolic (C) fractions
and resolution by SDS-PAGE, immunoblots were probed
for the indicated species (one experiment representative
of two to three replicates). Inset numbers represent rela-
tive signals for each protein in the nuclei after normaliza-
tion to lamin-A, with the nuclei of resting, previously acti-
vated WT cells set at 1.
(C and D) PKC-q reverses a defect mTORC2-deficient
T cells in TCR-CD28 costimulatory induction of NF-kB
transcriptional activity.
(C) Activated CD4+ T cells were transfected with the RE/
AP-luciferase reporter construct alongwith a constitutively
active Renilla luciferase, and restimulated with aCD3 and
aCD28. For relative activity, firefly luciferase was
measured 6 hr after restimulation and normalized for
transfection efficiency (one experiment representative of
three replicates).
(D) As in (C), except that cells also were cotransfected with
empty vector or vector encoding the kinase-active PKC-q
mutant and the data are pooled from two independent
replicates.
(E) Decreased expression of Bcl-3. As in (A), except that
the overall level of Bcl-3 was analyzed with whole-cell
extracts.
(F) mTORC2 promotes TCR-CD28-induction of ICAM-1
avidity. With lymph node T cells ± stimulation with aCD3
and aCD28, activation- and avidity-dependent binding of Fc-ICAM-1-aFc complexes to CD4+ T cells was measured by flow cytometry. The frequencies (%)
of ICAM-1-binding cells within the CD4+ gate are indicated by inset numbers, with results from two independent experiments summarized (right). Additional infor-
mation is provided in Figure S6.
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Akt sufficed to restore expression of Tbx21, a FoxO1-regulated
gene, but not Gata3, and a normal efficiency of Th1 but not Th2
cell differentiation. In contrast, PKC-q yielded the reciprocal
result.We conclude that the dominant function ofmTORC2under
physiological conditions in T cells is to guide differentiationmedi-
ated dichotomously by the mTORC2 targets Akt and PKC.
TOR was identified as the key target of a clinically important
immune suppressant drug rapamycin. Attention focused on the
capacity of this agent to inhibit proliferation and promote
apoptosis, but rapamycin was later shown to block Th1 cell
development, inhibit Th2 and Th17 cell differentiation, and
enhance the population of Treg cells in Th17 cultures (Blazar
et al., 1998; Kopf et al., 2007; Valmori et al., 2006). Loss of func-
tion for mTOR in T cells has been reported tomimic the effects of
rapamycin on T helper proliferation and differentiation and to
divert CD4+ T cells under helper-differentiating conditions into
FoxP3+ cells (Delgoffe et al., 2009). Signals that can reverse
these abnormalities are not known. The lack of mTOR was re-
ported to cause potentially meaningful decreases of IL-4-
induced STAT6 and IL-6-induced STAT3. It is intriguing to
compare these findings to those in the rictor-deficient state. Ric-
tor cKO T cells exhibited defects primarily of Th1 and Th2 cell750 Immunity 32, 743–753, June 25, 2010 ª2010 Elsevier Inc.differentiation and were not diverted into FoxP3+ status under
any condition promoting T helper effector differentiation,
although the prevalence of iTreg cell increased in response to
TGF-b under otherwise neutral conditions. Moreover, no defect
of STAT phosphorylation was detectable in either rictor-deficient
T cells or those inhibited for PI3K or mTOR. Collectively, these
data provide direct evidence that a rictor-deficient state leads
to attenuation of Th1 and Th2 cell differentiation without any
diversion into iTreg cell or apparent abnormality of STAT protein
induction by tyrosine phosphorylation. Instead, mTORC2 targets
Akt and PKC, and the activated kinases suffice to restore normal
differentiation to rictor cKO T cells.
Comparison of these results for mTORC2 and mTOR defi-
ciencies might suggest that the differences should be attribut-
able to mTORC1. This model is made more attractive because,
unlike the observation with splenocytes of rapamycin-treated
mice, prolonged rapamycin treatment of CD4+ T cells eliminated
Akt(HM) phosphorylation. Thus, mTORC1 might promote Th17
cell differentiation, repression of FoxP3 and the Treg cell state,
and perhaps the capacity of cytokines to induce tyrosine phos-
phorylation of STAT transcription factors. However, rapamycin
blocks mTOR activity without inhibiting IL-4-induced STAT6
phosphorylation, and even substantial reductions in P-STAT6
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Wang et al., 1997). Moreover, almost all signaling proteins ulti-
mately prove to serve in several heterologous complexes and
have multiple signal inputs. Although an alternative signaling
complex (McDonald et al., 2008) including rictormight contribute
to results reported with mTOR cKO T cells when mTOR is
depleted, the molecular epistasis results with active Akt and
PKC-q show that targets of mTORC2 suffice to revert the main
defects in T helper differentiation if mTORC1 is active. Because
Akt can liberate Rheb, a signal-transducing GTPase and acti-
vator of mTORC1, from repression by a Tsc1/Tsc2 complex (In-
oki et al., 2002), the attenuated Akt activation observed in rictor
cKO T cells might suggest a complex circuit involving mTORC1
in the data. Consistent with rictor or SIN1 null MEFs, however, we
observed normal activity of mTORC1 at least at the target kinase
S6K1. Moreover, T cell-specific Rheb depletion did not pheno-
copy loss of mTOR in terms of repressing FoxP3 (other compo-
nents of the Rheb-deficient phenotype are unknown) (Delgoffe
et al., 2009). Analysis of mTORC2 inactivation along with the
Rheb data suggests intriguing possibilities. These include that
the threshold for mTORC1 to repress FoxP3 is very low, so
that PI3K and Rheb-independent mTORC1 activation contrib-
utes to differences (Gwinn et al., 2008; Ha et al., 2006). Alterna-
tively, Rheb may function in a signaling pathway that impacts
FoxP3 in an mTORC1-independent manner, or each complex
(mTORC1, mTORC2) may independently mediate FoxP3 repres-
sion. Thus, although our data directly show that mTORC2 func-
tion is vital for Th1 and Th2 differentiation, mTORC1 is likely inde-
pendently to contribute to these processes.
Notwithstanding these issues pertaining to mTORC1, our data
underscore new features of mTOR in T cells. These include
mTORC2 as the predominant PDK2 activity driving costimula-
tion-enhanced HM phosphorylation and Akt activity and the
impact of this pathway on T-bet expression and Th1 cell differen-
tiation. Intriguingly, measurements comparing WT, heterozy-
gous (Cre+, Rictor fl/+), and homozygous cKO T cells found that
Th2 cell differentiation was strongly reduced at the intermediate
expression of mTORC2, whereas Th1 cell differentiation of
heterozygous cells was almost normal (data not shown). Thus,
mTORC2 may function as a scalar regulator of the balance
among T helper subsets so that when Akt activity is less affected,
Th1 cell differentiation is preserved. The findings also provide
evidence of an Akt-independent, PKC-dependent role for rictor
in T helper differentiation.
The cytoplasmic tail of CD28 stimulates PI3K activity by
collaboration of two separable transducer motifs and enhances
recruitment of both PDK1 and PKC-q into the immunological
synapse (Andres et al., 2004). The requirements for rictor in T
helper differentiation is similar to one aspect of signaling down-
stream from CD28 in that Myr-Akt reversed only the impairment
of Th1 cell, but not Th2 cell, differentiation observed when CD28
was absent (Kane et al., 2001). In terms of Th2 cell differentiation,
both CD28 and PKC-q are vital determinants of the efficiency of
Th2 cell differentiation (Andres et al., 2004). The finding that ric-
tor-deficient cells have reduced TCR-induced NF-kB activity,
GATA3, and Th2 cell differentiation reversible by constitutively
active PKC-q suggests that mTORC2 is a critical link connecting
costimulation to PKC-q and PI3K. Further, our data suggest that
this role connects to a well-established pathway in which PKC-qactivates NF-kB after TCR-CD28 stimulation by mobilizing
a Carma1, Bcl-10, MALT-1 signaling complex.
Expression of c-Maf, a potent regulator of Il4 transcription in
Th2 cell responses, was also rictor dependent. Vav1 couples
the TCR pathway to Maf (encoding c-Maf) (Tanaka et al.,
2005), but PI3K-PKB regulation is normal in Vav-deficient
T cells (Wood et al., 2006). IL-6 collaborates with this TCR signal
to induce c-Maf via STAT3 (Yang et al., 2005). However, rictor
cKO cells had normal STAT3 induction and were reverted by
PKC-q. Thus, mTORC2 probably relays signals essential for c-
Maf induction by a pathway that collaborates with but is parallel
to these previously establishedmechanisms.More generally, the
data indicate that loss of mTORC2 impairs a subset of biological
targets of mTOR in T cells and acts via protein kinases B or C
without an impact on cytokine-induced Stat protein tyrosine
phosphorylation. This selectivity suggests the possibility of alter-
nate therapeutic windows for agents that would impair mTORC2
function, for disease states in which complete mTOR inhibition
might add toxicities but not benefits.
EXPERIMENTAL PROCEDURES
Mice, Antibodies, and Reagents
Rictorfl/fl mice were bred to a B6 background. For T cell lineage-specific dele-
tion, Rictorfl/fl mice were crossed with transgenic mice expressing codon-opti-
mized Cre recombinase (iCre) under control of the distal promoter of Lck gene
(Zhang et al., 2005). Mice were maintained in ventilated microisolator cages in
specified pathogen-free conditions and used in accordance with IACUC regu-
lations of Vanderbilt University. Sources of chemical and biological reagents
(cytokines, antibodies) detailed in Supplemental Experimental Procedures.
Cell Culture and Retroviral Transduction
CD4+ cells were purified by positive selection with aCD4-conjugated magnetic
beads (Miltyeni Biotec). Lymphoid cells were cultured, proliferation assays
were performed, and virions were generated after transfection of FNX eco-
tropic packaging cells with constructs of Akt(DD) and Akt(DA) mutants
(T308D, S473D, or S473D A), Myr-Akt, and PKC-q in MSCV-IRES-GFP and
-Thy1.1 (MiG RV, MiT RV, respectively) as described (Corn et al., 2003). Acti-
vated CD4 T cells were ‘‘spinfected’’ and then cultured in Th1 or Th2 cell condi-
tions. For in vitro T helper cell differentiation, lymph node cells were activated
with plate-bound aCD3 plus soluble aCD28 and cultured with IL-2. Subset-
specific culture additions were: anti-IL-4 and IL-12 (Th1 cell culture), aIL-12,
aIFN-g, and mIL-4 (Th2 cell culture), or TGF-b, IL6, IL-23, aIL-4, aIL-12, and
aIFN-g (Th17 cell conditions). After 5 days, cells were restimulated with
plate-bound 0.5 mg/ml aCD3 and soluble 0.5 mg/ml aCD28, stained for CD4,
intracellular IFN-g, and IL-4 as described (Corn et al., 2003), or restimulated
to yield culture supernatants and measure cytokine production by ELISA.
Details are tabulated in Supplemental Experimental Procedures.
Transfection and Luciferase Assays
Activated T cells (43 106 /sample) were rested in IL-2-freemedium for 5 hr and
cotransfected with 20 mg of RE/AP reporter DNA, 5 mg of TK-pRL (Promega),
and, where indicated, 10 mg of MSCV or MSCV-PKC-q-KA with the Mouse
T cells Nucleofector kit (Amaxa). Transfectants were returned to culture 4 hr
and restimulated (1 mg/ml aCD3 and 1 mg/ml aCD28) for 6 hr. Luciferase assays
were performed with the Dual-luciferase kit (Promega). NF-kB-driven firefly
luciferase activity was determined with a luminometer and normalized to Re-
nilla luciferase activity.
Immunoblotting and Akt In Vitro Kinase Assay
Proteins in cell extracts were prepared and analyzed as described (Mora et al.,
2003) with appropriate IR dye-conjugated second Abs and laser excitation/
quantitative fluorescence detection (Odyssey Infrared Imaging System
[Li-Cor]). To analyze cytosolic and nuclear proteins, previously activated
T cells were washed and fractionated into cytosolic and nuclear portions asImmunity 32, 743–753, June 25, 2010 ª2010 Elsevier Inc. 751
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CD4 T Cells Regulated by TORC2 via Distinct Relaysdescribed (Sun et al., 2000). Tomeasure Akt activity, aAkt immunoprecipitates
of lysate proteins were used for in vitro kinase assays of GSK-3a/b (S21/S9)
phosphorylation in accordance with kit instructions (Cell Signaling Tech-
nology). For each sample, Akt kinase activity determined by immunoblotting
was normalized to the Akt in immune complexes.
Flow Cytometry, Cell Division, and TUNEL Assays
Cells were stained with Ab, or stained, fixed, permeabilized, and then further
processed for detection of intracellular epitopes, all as described (Corn et al.,
2003). For division measurement, cells were fluorescein-labeled with CFSE
(1 mM, 5 min), activated as described for TdR incorporation, cultured 48 hr,
stainedwithanti-CD4andanti-CD8, andanalyzed by FACS. Sphase entry rates
were analyzed 24 hr after activation by plate-bound aCD3 (1 mg/ml) and soluble
aCD28 (1mg/ml), labelingwithBrdU (6 hr),CD4andCD8staining, processing for
DNaseI digestion, aBrdU staining, and flow cytometry analysis as described
(Corn et al., 2003). For apoptosis assay, cells cultured in the presence or
absence of 10 ng/ml IL-4 for 20 hr, with or without irradiation (2 Gy) in a 137Cs
irradiator, were stained for surface markers, subjected to TUNEL assays, and
analyzed by flow cytometry in comparison to control reactions lacking TdT.
Immunizations, ELISA, and ELISPOT Assays
Mice were injected intraperitoneally (i.p.) with 20 mg KLH in incomplete
Freund’s adjuvant (IFA) and boosted (20 mg KLH in IFA) 2 weeks later. Sera
collected 5 days after the boost (19 days after primary immunization) were
analyzed by isotype-specific capture ELISA. For IgG1 and IgE responses,
mice were immunized twice with 20 mg low-endotoxin ovalbumin (Hyglos
GmbH, Germany) in alum (Imject, Pierce) at a 1 week interval. Sera collected
19 days after the first immunization were analyzed for ovalbumin-specific
IgG, IgG1, and IgE by capture ELISA. Alternatively, micewere immunized intra-
venously with Listeria monocytogenes (5 3 104 colony-forming units/mouse),
and analyzed for IFN-g expression by FACS and ELISPOT assays 6 days after
infection. ELISPOT assays from two independent experiments with n = 8 (WT)
and 6 (cKO) mice were performed by stimulating portions of the same exper-
imental samples with 10 nM and 100 nM of the class II MHC-restricted
LLO190-201 peptide.
Ligand-Complex-Based Adhesion Assay
Avidity-dependent assays of ICAM-1 binding were performed as described
(Konstandin et al., 2007) with minor modifications. ICAM-1-human Fc (Fc-
ICAM-1, R&D Systems) was incubated with biotinylated anti-human IgG Fc
(eBioscience) in PBS at 4C. Freshly isolated LN cells were incubated with
Fc-ICAM-1-aIgG Fc complexes in the presence or absence of 10 mg/ml anti-
CD3 and 2 mg/ml anti-CD28 for 20 min, washed with PBS, fixed with 4% para-
formaldehyde, and stained with streptavidin-PerCP and CD4-APC.
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